Why Is Integra LifeSciences Stock Soaring On Monday?

On Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported third-quarter adjusted EPS of $0.41, down from $0.76 a year ago, beating the consensus of $0.39.

The company reported sales of $380.83 million, beating the consensus of $375.78 million.

Third-quarter revenues of $380.8 million decreased 0.4% on a reported basis and 8.6% on an organic basis compared to the prior year. Revenue decreased by 10.3% on an organic basis, excluding Boston.

Codman Specialty Surgical segment sales increased 1% to $270.8 ...